Your browser doesn't support javascript.
loading
Prevalence of Diabetes in Tuberculosis Patients in Kathmandu Valley, Nepal.
Hirayama, Takanori; Gopali, Ram Sharan; Maharjan, Bijay; Shibasaki, Kenichi; Shrestha, Ashish; Thapa, Anil; Verma, Sharat Chandra; Bhattarai, Jyoti; Sakurada, Shinsaku; Nakano, Takashi; Sano, Kouichi.
Afiliación
  • Hirayama T; National Center for Global Health and Medicine, Japan.
  • Gopali RS; Department of Microbiology, Osaka Medical Collage, Japan.
  • Maharjan B; Japan-Nepal Health and Tuberculosis Research Association, Nepal.
  • Shibasaki K; Japan-Nepal Health and Tuberculosis Research Association, Nepal.
  • Shrestha A; National Institute of Infectious Diseases, Japan.
  • Thapa A; National Tuberculosis Center, Nepal.
  • Verma SC; National Tuberculosis Center, Nepal.
  • Bhattarai J; National Tuberculosis Center, Nepal.
  • Sakurada S; Metro Hospital, Nepal.
  • Nakano T; Narita International Airport Quarantine Station, Japan.
  • Sano K; Department of Microbiology, Osaka Medical Collage, Japan.
Jpn J Infect Dis ; 74(6): 507-510, 2021 11 22.
Article en En | MEDLINE | ID: mdl-33790063
ABSTRACT
In this descriptive cross-sectional study, the data on the prevalence of diabetes mellitus (DM) among tuberculosis (TB) patients at the Urban Directly Observed Treatment Centers in the Kathmandu, Bhaktapur, and Lalitpur districts of Nepal were collected. The prevalence of DM was assessed in 67 previously treated TB (PTTB) and 214 new TB patients. DM was diagnosed in 8 PTTB and 20 new TB patients. Clinical interviews identified 14 patients with DM, rapid blood glucose test was used to diagnose DM in 4 patients, and oral glucose tolerance test was used to diagnose DM in another 4 patients. Impaired glucose tolerance and impaired fasting glycemia were observed in 8 and 5 patients, respectively. The 18-24-year age group had the largest number of new TB patients (82, 38.3%). However, the incidence of DM among TB patients was higher in the >35-year age group. Moreover, DM was diagnosed in 24.2% of PTTB patients and in 23.1% of new TB patients. To determine the impact of DM screening in TB patients, a larger number of samples should be analyzed. DM screening for patients with TB is expected to start in developing countries. This should be initiated by conducting clinical interviews about DM and glucose tests using rapid kits.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis / Glucemia / Diabetes Mellitus Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Jpn J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis / Glucemia / Diabetes Mellitus Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Jpn J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Japón